https://www.hsbcinnovationbanking.com/us/en/business-stage/hsbc-healthcare-reports

Hosts:

Joseph Snyder

Head of Talent and Co-Founder, Lifeblood

https://www.linkedin.com/in/josephasnyder1/

Cristiano Fontana

Head of Advisory, Lifeblood

https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/

Guests:

Jonathan Norris

Managing Director, VC Relationship Managment, HSBC Innovation Banking

Jonathan Norris is a Managing Director at HSBC Innovation, with over two decades of experience in the healthcare and life sciences sector. A former litigation attorney, Jonathan has been immersed in healthcare investing since 1999, with a particular focus on equity and debt strategy across BioPharma, Medical Devices, Diagnostics/Tools, and Digital Health.

At HSBC Innovation, Jonathan advises both investors and executives by analyzing historical and current market trends, including venture investments, IPO activity, and M&A. He regularly supports C-level leadership with business planning, exit strategy, and access to capital, and is known for his insightful thought leadership on healthcare venture funding and deal flow.

Jonathan has authored numerous analyses on the flow of capital into the healthcare ecosystem and continues to be a trusted voice in the industry, helping shape strategic decision-making for both startups and investors.

https://www.linkedin.com/in/jonathan-norris-248556/

Hosts:

Joseph Snyder

Head of Talent and Co-Founder, Lifeblood

https://www.linkedin.com/in/josephasnyder1/

Cristiano Fontana

Head of Advisory, Lifeblood

https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/

Guests:

Kavita Bouknight

CEO, Match Health Collective

Kavita Bouknight is the CEO of Match Health Collective which specializes in MedTech marketing, messaging, and design. Their work focuses on building compelling brand identities, developing cohesive visual design, crafting strategic messaging frameworks, and creating pitch-ready content and go-to-market strategies to drive visibility and accelerate adoption.

https://www.linkedin.com/in/kavitabouknight/

Martin Gomez

Partner, Goodwin

Co-leading the MedTech and Artificial Intelligence practice across IP, company formation, licensing, fundraising, an strategic transactions or exits.

From FDA expectations to real-world applications, we explore what’s hype, what’s real, and what founders need to know to integrate AI responsibly. Tune in as they explore how AI is shaping product development, regulatory hurdles, and investor expectations across the MedTech landscape.

https://www.linkedin.com/in/martin-gomez-898556113/

Hosts:

Joseph Snyder

Head of Talent and Co-Founder, Lifeblood

https://www.linkedin.com/in/josephasnyder1/

Cristiano Fontana

Head of Advisory, Lifeblood

https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/

Guests:

Darcy Bachert

CEO, Prolucid

Darcy Bachert is the Founder and CEO of Prolucid, an ISO-13485 certified software engineering firm that specializes in custom medical software development. Over the past 17 years Darcy has grown Prolucid to a team of 25, supporting innovative MedTech companies across the world in successfully bringing their applications and devices to market

https://www.linkedin.com/in/darcybachert/

Robert Hamilton

CEO, NeuraSignal Inc.

Robert is a seasoned healthcare entrepreneur, executive, and engineer with a deep commitment to driving transformative innovation in medicine. With a passion for aligning bold vision with high-performing teams, he has spent his career tackling some of the most complex challenges in healthcare.

Robert’s vision and leadership continue to place NeuraSignal at the forefront of AI-powered neurodiagnostics, advancing the future of brain health.

https://www.linkedin.com/in/hamiltonrobert/

Carmen Brown

Senior Manager of Regulatory Affairs, Proxima

Carmen Brown is a Senior Regulatory Affairs Manager at Proxima Clinical Research, Inc. with 10 years of work experience in the pharmaceutical and medical device industry. Carmen has a master’s in public health and a bachelor’s degree in chemistry. At Proxima, Carmen has worked on both drug products and medical devices specializing in combination products. Her expertise spans a wide variety of therapeutic areas including oncology and IVDs that have included AI/ML.

https://www.linkedin.com/in/carmen-brown-068462a6/